Back to search

Article

ZFP36 as a Key Regulator of CD4+ T Cell Subset Balance in Immune Checkpoint Inhibitor-Induced Adverse Events in Lung Adenocarcinoma

2025-09-23

Abstract excerpt

<title>Abstract</title> <p> <bold>Background:</bold> Immune checkpoint inhibitors (ICIs) have revolutionized lung adenocarcinoma (LUAD) treatment but are frequently accompanied by immune-related adverse events (irAEs). The zinc finger protein 36 (ZFP36), also known as tristetraprolin, serves as a critical post-transcriptional regulator of mRNA stability and has emerged as a key modulator of T cell function. How...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c9057c88-5f9c-50e8-9cd4-c971c61cb203
DOI
10.21203/rs.3.rs-7339858/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ZFP36 as a Key Regulator of CD4+ T Cell Subset Balance in Immune Checkpoint Inhibitor-Induced Adverse Events in Lung AdenocarcinomaDOI 10.21203/rs.3.rs-7339858/v1
Select a neighboring publication to make it the new centre.